Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Academic Institution
No.
Sign in or Register to read more
14494
Related Questions
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
Are there any special treatment considerations when treating a patient with laryngeal cancer with significant Reinke's edema of the vocal folds?
How would you approach patients with high risk mucoepidermoid carcinoma (high grade) of the parotid gland for optimal adjuvant treatment?
Would you recommend adjuvant neck radiation for metastatic chordoma to cervical lymph node, s/p neck dissection, with 1/10 positive nodes and no residual on post op imaging?
How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?
How would you approach cT3N0M0 squamous cell carcinoma of the supraglottic larynx in a patient with a history of breast cancer and prior radiation to the supraclavicular fossa?
What is the recommended adjuvant dose for neuroendocrine cancer in the head and neck?
Is there a role for radiation in biphenotypic sinonasal sarcoma?
How would you manage a presumed radiation induced sarcoma of the head and neck?
What changes do you make in the management of non-endemic nasopharynx cancer compared to endemic?